Search Results
-
Common genetic profile linked to drug reaction
New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.
-
COVID-19 vaccines for 5- to 11-year-olds
Answers to frequently asked questions as COVID-19 vaccinations roll out for children as young as 5.
-
When can you vaccinate your kids?
Stanford pediatricians helped conduct clinical trials of COVID-19 vaccines for children. Data from the study will be submitted to the Food and Drug Administration for consideration.
-
Allergies to COVID-19 vaccines mostly mild
In a study of mRNA-based COVID-19 vaccine doses given at Stanford Medicine, vaccine allergies were rare, mild and mostly triggered by a vaccine additive, not the mRNA.
-
Severe COVID-19, autoantibodies linked
A study spearheaded by Stanford researchers indicates that at least 1 in 5 hospitalized COVID-19 patients develops new antibodies that attack their own tissue within a week of admission.
-
Tips for kids’ back-to-school anxiety
Returning to school as the pandemic stretches on may spark anxiety in young students, but there are approaches parents can use to build children’s resilience.
-
Winslow leads national COVID-19 group
A professor of medicine and former Air Force colonel, Winslow temporarily relocated to Washington to head an interagency group responding to this pandemic and preparing for the next one.
-
COVID-19 symptoms and prior common colds
In COVID-19 patients whose symptoms were mild, Stanford researchers found that they were more likely than sicker patients to have signs of prior infection by similar, less virulent coronaviruses.
-
Evidence COVID-19 causes brain inflammation
A detailed molecular analysis of tissue from the brains of individuals who died of COVID-19 reveals extensive signs of inflammation and neurodegeneration, but no sign of the virus that causes the disease.
-
COVID-19 hospitalizations among kids likely overcounted
Children being treated in hospitals are tested for SARS-CoV-2, but many who test positive never develop COVID-19 symptoms, leading to overestimates of disease severity, a study found.